GL1X · GenesisL1 explorer

Research workbench

Co-structure of human glycogen synthase kinase beta with a selective (5-imidazol-2-yl-4-phenylpyrimidin-2-YL)[2-(2-pyridylamino) ETHYL]AMINE inhibitor

Analyse Co-structure of human glycogen synthase kinase beta with a selective… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6B8J
Type
protein
Length
349 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta; Val-sep-arg-arg
EC
2.7.11.26, 2.7.11.1
UniProt
P49841
Ligands
65C
Pockets
3 · best druggability 0.65

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein34533% helix, 18% strandP49841
CVal-sep-arg-argprotein40% helix, 25% strand—

Ligands and binding sites

  • 65C · Chir99021 · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12350.650.822865C
22290.510.7633empty
3590.300.7518empty

Interfaces

1 interface between chains.

  • A–C · 353 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 6B8J · Co-structure of human glycogen synthase kinase beta with a selective… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.